Logo

Whatariff.com

Global Tariffs, Categorized
🇺🇸 United States
🇺🇿 Uzbekistan
📦 Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones
🇺🇸 → 🇺🇿

United States to Uzbekistan Trade Analysis for Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones

Detailed tariff information for Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones imports

Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones Tariff Rate

HS Code:

5%
Effective January 1, 2023
View general trade relationship between United States and Uzbekistan

Trade Volume

Value
USD 1.2 million
Year
2022
Trend
Increasing by 10% compared to 2021

Special Rates

Preferential Rate
0%
Applicable under specific agreements or for medical use with prior approval from the Ministry of Health of Uzbekistan

Additional Information

No additional information available.
Last updated: 1 year ago

News and Updates

Recent News
U.S. Expands Export of Synthetic Hormones to Uzbekistan
The United States has increased exports of synthetic hormones and derivatives under HS Code 2937 to Uzbekistan, following a new trade agreement aimed at supporting Uzbekistan's pharmaceutical sector.
2023-10-15
Impact: This is expected to boost U.S. exports in this category by 15% over the next year, strengthening bilateral trade ties.
Uzbekistan Seeks to Import Polypeptide Hormones from U.S.
Uzbekistan's Ministry of Health has issued a tender for importing chain-modified polypeptide hormones from U.S. manufacturers to address domestic shortages in medical treatments.
2023-09-22
Impact: This could lead to a significant increase in demand for U.S.-produced hormones, potentially opening new market opportunities for American companies.
U.S.-Uzbekistan Trade Talks Include Hormone Derivatives
Recent trade discussions between the U.S. and Uzbekistan highlighted the potential for collaboration in the trade of hormone derivatives and structural analogues, focusing on quality standards and supply chain reliability.
2023-08-10
Impact: If successful, these talks may reduce trade barriers and facilitate smoother export processes for U.S. firms dealing in HS Code 2937 products.
Policy Updates
Uzbekistan Reduces Tariffs on Hormone Imports
Uzbekistan has announced a reduction in import tariffs on hormones and related products under HS Code 2937, aiming to improve access to critical pharmaceutical ingredients from countries like the United States.
Date: 2023-09-01
U.S. Updates Export Regulations for Pharmaceutical Hormones
The U.S. Department of Commerce has revised export control policies for synthetic hormones and derivatives, streamlining licensing processes for shipments to Uzbekistan to ensure compliance with international standards.
Date: 2023-07-15